Long-term immunosuppressive treatment of serpiginous choroiditis

Esen K Akpek, Stefanos Baltatzis, Jean Yang, C. Stephen Foster

Research output: Contribution to journalArticle

Abstract

Objective: To determine the efficacy of immunosuppressive treatment in serpiginous choroiditis. Design: The clinical courses were reviewed of six consecutive patients (12 eyes) with vision-threatening, steroid-dependent/resistant serpiginous choroiditis treated with a combination of immunosuppressive agents including azathioprine, cyclosporine, and cyclophosphamide. All patients underwent treatment for at least 12 months. Results: The follow-up period ranged from 17 to 105 months (mean 57, median 43). All patients were able to taper oral steroids. Five patients discontinued all immunosuppressive medications after a treatment period of 12 to 69 months (mean 39 months). Immunosuppressive treatment was continued in one patient at a 'low' maintenance dose. Ten eyes had improved visual acuities, while vision remained impaired in two due to macular scars. Recurrence was noted in two patients when an attempt was made to decrease the dose of immunosuppressive medication. Two patients experienced side effects which were reversed by decreasing the dose of the medications. Conclusion: Long-term immunosuppressive treatment appears to prolong remission and preserve vision in patients with serpiginous choroiditis.

Original languageEnglish (US)
Pages (from-to)153-167
Number of pages15
JournalOcular Immunology and Inflammation
Volume9
Issue number3
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Choroiditis
Immunosuppressive Agents
Therapeutics
Steroids
Azathioprine
Cyclophosphamide
Cyclosporine
Visual Acuity
Cicatrix
Recurrence

Keywords

  • Immunosuppression
  • Long-term treatment
  • Serpiginous choroiditis

ASJC Scopus subject areas

  • Ophthalmology
  • Immunology and Allergy

Cite this

Long-term immunosuppressive treatment of serpiginous choroiditis. / Akpek, Esen K; Baltatzis, Stefanos; Yang, Jean; Foster, C. Stephen.

In: Ocular Immunology and Inflammation, Vol. 9, No. 3, 2001, p. 153-167.

Research output: Contribution to journalArticle

Akpek, Esen K ; Baltatzis, Stefanos ; Yang, Jean ; Foster, C. Stephen. / Long-term immunosuppressive treatment of serpiginous choroiditis. In: Ocular Immunology and Inflammation. 2001 ; Vol. 9, No. 3. pp. 153-167.
@article{d3a26484fb4f47d2969d22b6c9af5ed2,
title = "Long-term immunosuppressive treatment of serpiginous choroiditis",
abstract = "Objective: To determine the efficacy of immunosuppressive treatment in serpiginous choroiditis. Design: The clinical courses were reviewed of six consecutive patients (12 eyes) with vision-threatening, steroid-dependent/resistant serpiginous choroiditis treated with a combination of immunosuppressive agents including azathioprine, cyclosporine, and cyclophosphamide. All patients underwent treatment for at least 12 months. Results: The follow-up period ranged from 17 to 105 months (mean 57, median 43). All patients were able to taper oral steroids. Five patients discontinued all immunosuppressive medications after a treatment period of 12 to 69 months (mean 39 months). Immunosuppressive treatment was continued in one patient at a 'low' maintenance dose. Ten eyes had improved visual acuities, while vision remained impaired in two due to macular scars. Recurrence was noted in two patients when an attempt was made to decrease the dose of immunosuppressive medication. Two patients experienced side effects which were reversed by decreasing the dose of the medications. Conclusion: Long-term immunosuppressive treatment appears to prolong remission and preserve vision in patients with serpiginous choroiditis.",
keywords = "Immunosuppression, Long-term treatment, Serpiginous choroiditis",
author = "Akpek, {Esen K} and Stefanos Baltatzis and Jean Yang and Foster, {C. Stephen}",
year = "2001",
doi = "10.1076/ocii.9.3.153.3962",
language = "English (US)",
volume = "9",
pages = "153--167",
journal = "Ocular Immunology and Inflammation",
issn = "0927-3948",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Long-term immunosuppressive treatment of serpiginous choroiditis

AU - Akpek, Esen K

AU - Baltatzis, Stefanos

AU - Yang, Jean

AU - Foster, C. Stephen

PY - 2001

Y1 - 2001

N2 - Objective: To determine the efficacy of immunosuppressive treatment in serpiginous choroiditis. Design: The clinical courses were reviewed of six consecutive patients (12 eyes) with vision-threatening, steroid-dependent/resistant serpiginous choroiditis treated with a combination of immunosuppressive agents including azathioprine, cyclosporine, and cyclophosphamide. All patients underwent treatment for at least 12 months. Results: The follow-up period ranged from 17 to 105 months (mean 57, median 43). All patients were able to taper oral steroids. Five patients discontinued all immunosuppressive medications after a treatment period of 12 to 69 months (mean 39 months). Immunosuppressive treatment was continued in one patient at a 'low' maintenance dose. Ten eyes had improved visual acuities, while vision remained impaired in two due to macular scars. Recurrence was noted in two patients when an attempt was made to decrease the dose of immunosuppressive medication. Two patients experienced side effects which were reversed by decreasing the dose of the medications. Conclusion: Long-term immunosuppressive treatment appears to prolong remission and preserve vision in patients with serpiginous choroiditis.

AB - Objective: To determine the efficacy of immunosuppressive treatment in serpiginous choroiditis. Design: The clinical courses were reviewed of six consecutive patients (12 eyes) with vision-threatening, steroid-dependent/resistant serpiginous choroiditis treated with a combination of immunosuppressive agents including azathioprine, cyclosporine, and cyclophosphamide. All patients underwent treatment for at least 12 months. Results: The follow-up period ranged from 17 to 105 months (mean 57, median 43). All patients were able to taper oral steroids. Five patients discontinued all immunosuppressive medications after a treatment period of 12 to 69 months (mean 39 months). Immunosuppressive treatment was continued in one patient at a 'low' maintenance dose. Ten eyes had improved visual acuities, while vision remained impaired in two due to macular scars. Recurrence was noted in two patients when an attempt was made to decrease the dose of immunosuppressive medication. Two patients experienced side effects which were reversed by decreasing the dose of the medications. Conclusion: Long-term immunosuppressive treatment appears to prolong remission and preserve vision in patients with serpiginous choroiditis.

KW - Immunosuppression

KW - Long-term treatment

KW - Serpiginous choroiditis

UR - http://www.scopus.com/inward/record.url?scp=0035715007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035715007&partnerID=8YFLogxK

U2 - 10.1076/ocii.9.3.153.3962

DO - 10.1076/ocii.9.3.153.3962

M3 - Article

VL - 9

SP - 153

EP - 167

JO - Ocular Immunology and Inflammation

JF - Ocular Immunology and Inflammation

SN - 0927-3948

IS - 3

ER -